FDA product code OWM: Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

OWM is the FDA product code for prostate-specific antigen (psa) for prognostic, recurrence risk assessment of prostate cancers. It is a Class II device, regulated under 21 CFR 866.6040 and reviewed by the Pathology panel. FDA has cleared 1 510(k) submission under OWM. The average 510(k) review took 510 days (median 510).

Definition

Determines rate of increase of total prostate specific antigen at ultrasensitive concentration levels (picogram/ml serum), and identifies those patients following prostatectomies which are at reduced risk for recurrence of prostate cancer.

Classification

FieldValue
Device nameProstate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
Device classClass II
Regulation21 CFR 866.6040
Review panelPA — Pathology
Medical specialtyImmunology
Premarket route510(k)

Compare with all 510(k) review times · Search every OWM clearance

Top OWM applicants

ApplicantClearancesLatest
Iris Molecular Diagnostics12011-09-20

Most recent OWM clearances

510(k)ApplicantDeviceDecision dateReview days
K101185Iris Molecular DiagnosticsNUCLEIC ACID DETECTION IMMUNOASSAY (NADIA) PSA ASSAY2011-09-20510

Recalls for OWM devices

openFDA lists no recalls for product code OWM.

Frequently asked questions

What is FDA product code OWM?

OWM is the FDA product code for prostate-specific antigen (psa) for prognostic, recurrence risk assessment of prostate cancers. It is a Class II device, regulated under 21 CFR 866.6040 and reviewed by the Pathology panel.

What device class is OWM?

Class II, regulation 21 CFR 866.6040. Typical premarket route: 510(k).

How long does a 510(k) take for product code OWM?

Across 1 cleared submissions the average was 510 days from receipt to decision (median 510).

Which companies have the most OWM clearances?

Iris Molecular Diagnostics (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times